Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Theravance: A $1.5 Billion Company With An $8 Billion Product
Theravance: A $1.5 Billion Company With An $8 Billion Product
Theravance: A $1.5 Billion Company With An $8 Billion Product
Submitted by
admin
on February 22, 2012 - 5:47pm
Source:
Seeking Alpha
News Tags:
Theravance
GSK
Pfizer
Relovair
Advair
AstraZeneca
asthma
COPD
Headline:
Theravance: A $1.5 Billion Company With An $8 Billion Product
Do Not Allow Advertisers to Use My Personal information
